News

A new blood-based four-protein panel, when combined with a lung cancer risk model, can better identify those at high risk of dying from lung cancer than the current criteria, study suggests.

MD Anderson-led study maps all normal breast cells, bringing new understanding with potential impact for breast cancer and other breast diseases.

According to research, a combination of drugs was dramatically more effective and less prone to resistance than treatment with a KRAS inhibitor alone for pancreatic cancer.

Dr. Yannick Benoit, the study’s co-first author, says the collaborative research team has established a clear link between different types of cancers and their embryonic origins.

Research suggests that glioblastoma cells can coordinate throughout the whole tumor to better resist chemotherapy and radiation.

A degradable, polymer-based nanoparticle packaging system has shown potential for improving the delivery of mRNA cancer vaccines and vaccines for infectious diseases.

New research has illustrated that activating the immune complement system can enhance cancer immunotherapies.

University of Oxford Professor Fritz Vollrath puts forth his “hot testicle hypothesis”. Vollrath suggests that elephants may carry more copies of p53 encoding genes due to an evolutionary mechanism that functions to protect sperm against harsh temperatures, but serendipitously offers cancer protection.

Researchers have shed light on a potential therapeutic target to halt the invasion and spread of cancer cells, also providing a prognostic marker to help treatment selection.

A new study identifies seven risk factors that convey higher-than-average risk for early-onset colorectal cancer in males.